23 October 2019 - Deborah Wilkes
Archived
Moberg Pharma has signed an exclusive South Korean distribution agreement for MOB-015, its novel topical terbinafine formulation for treating nail fungus.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.